scholarly article | Q13442814 |
P2093 | author name string | Bishop GA | |
Busch LK | |||
P433 | issue | 5 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | membrane protein | Q423042 |
P304 | page(s) | 2555-2561 | |
P577 | publication date | 1999-03-01 | |
P1433 | published in | Journal of Immunology | Q3521441 |
P1476 | title | The EBV transforming protein, latent membrane protein 1, mimics and cooperates with CD40 signaling in B lymphocytes | |
P478 | volume | 162 |
Q35147016 | CD40 ligand is a critical effector of Epstein-Barr virus in host cell survival and transformation |
Q36369236 | Differential signaling and tumor necrosis factor receptor-associated factor (TRAF) degradation mediated by CD40 and the Epstein-Barr virus oncoprotein latent membrane protein 1 (LMP1). |
Q27345929 | Epstein-Barr virus LMP2A reduces hyperactivation induced by LMP1 to restore normal B cell phenotype in transgenic mice |
Q26830464 | Epstein-Barr virus in systemic lupus erythematosus, rheumatoid arthritis and multiple sclerosis—association and causation |
Q39451096 | Epstein-Barr virus suppresses a G(2)/M checkpoint activated by genotoxins |
Q55024423 | Epstein-Barr virus-encoded microRNAs as regulators in host immune responses. |
Q30442797 | Human CD4(+) T lymphocytes consistently respond to the latent Epstein-Barr virus nuclear antigen EBNA1. |
Q34622693 | Latent Membrane Protein 1, the EBV-Encoded Oncogenic Mimic of CD40, Accelerates Autoimmunity in B6.Sle1 Mice |
Q36747951 | Molecular basis of cytotoxicity of Epstein-Barr virus (EBV) latent membrane protein 1 (LMP1) in EBV latency III B cells: LMP1 induces type II ligand-independent autoactivation of CD95/Fas with caspase 8-mediated apoptosis |
Q34696221 | Molecular mechanisms of TNFR-associated factor 6 (TRAF6) utilization by the oncogenic viral mimic of CD40, latent membrane protein 1 (LMP1). |
Q36961875 | Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor. |
Q36403897 | Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytes |
Q38999750 | Reversion of apoptotic resistance of TP53-mutated Burkitt lymphoma B-cells to spindle poisons by exogenous activation of JNK and p38 MAP kinases |
Q37093324 | Role of NF-kappa B in cell survival and transcription of latent membrane protein 1-expressing or Epstein-Barr virus latency III-infected cells |
Q39814540 | Roles of the TRAF2/3 binding site in differential B cell signaling by CD40 and its viral oncogenic mimic, LMP1 |
Q34364910 | Roles of the kinase TAK1 in TRAF6-dependent signaling by CD40 and its oncogenic viral mimic, LMP1 |
Q34397107 | Signaling by CD40 and its mimics in B cell activation |
Q41718695 | TRAF binding is required for a distinct subset of in vivo B cell functions of the oncoprotein LMP1. |
Q38801811 | TRAF3 as a powerful and multitalented regulator of lymphocyte functions. |
Q37386105 | TRAF5 is a critical mediator of in vitro signals and in vivo functions of LMP1, the viral oncogenic mimic of CD40. |
Q39060065 | TRAF5 negatively regulates TLR signaling in B lymphocytes |
Q28361340 | TRAF6 is a critical mediator of signal transduction by the viral oncogene latent membrane protein 1 |
Q37610522 | TRAF6 is a critical regulator of LMP1 functions in vivo. |
Q89777732 | The oncogenic membrane protein LMP1 sequesters TRAF3 in B-cell lymphoma cells to produce functional TRAF3 deficiency |
Q57169059 | Transmembrane Domains Mediate Intra- and Extracellular Trafficking of Epstein-Barr Virus Latent Membrane Protein 1 |
Q40714517 | Unimpaired activation of c-Jun NH2-terminal kinase (JNK) 1 upon CD40 stimulation in B cells of patients with X-linked agammaglobulinemia |
Search more.